Burden and Quality of Life Among Female and Male Patients with Heart Failure in Europe: A Real-World Cross-Sectional Study

References

• Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18:891–975.
   PubMed Web of Science ®Google Scholar
• Milinković I, Giuseppe R, Lopatin Y, Seferović PM. The role of ivabradine and trimetazidine in the new ESC HF guidelines. Cardiac Failure Rev. 2016;2:123.
   Google Scholar
• Westenbrink BD, Brugts JJ, McDonagh TA, Filippatos G, Ruschitzka F, Van Laake LW. Heart failure specialization in Europe. Eur J Heart Fail. 2016;18:347–349. doi:10.1002/ejhf.506
   Web of Science ®Google Scholar
• Khavjou O, Phelps D, Leib A. Projections of Cardiovascular Disease Prevalence and Costs: 2015–2035. Technical report; 2016. Available from: https://healthmetrics.heart.org/wp-content/uploads/2017/10/Projections-of-Cardiovascular-Disease.pdf. Accessed July 8, 2021.
   Google Scholar
• Jeon YH, Kraus SG, Jowsey T, Glasgow NJ. The experience of living with chronic heart failure: a narrative review of qualitative studies. BMC Health Serv Res. 2010;10:77. doi:10.1186/1472-6963-10-77
   PubMed Web of Science ®Google Scholar
• Stewart S, Ekman I, Ekman T, Odén A, Rosengren A. Population impact of heart failure and the most common forms of cancer: a study of 1 162 309 hospital cases in Sweden (1988 to 2004). Circ-Cardiovasc Qual. 2010;3:573–580. doi:10.1161/CIRCOUTCOMES.110.957571
   PubMed Web of Science ®Google Scholar
• Norberg EB, Boman K, Löfgren B. Activities of daily living for old persons in primary health care with chronic heart failure. Scand J Caring Sci. 2008;22:203–210. doi:10.1111/j.1471-6712.2007.00514.x
   PubMed Web of Science ®Google Scholar
• Heart Failure Policy Network; 2020. Heart failure policy and practice in Europe. London: HFPN. Available from: https://www.healthpolicypartnership.com/app/uploads/Heart-failure-policy-and-practice-in-Europe.pdf.
   Google Scholar
• Lesman-Leegte I, Jaarsma T, Coyne JC, Hillege HL, Van Veldhuisen DJ, Sanderman R. Quality of life and depressive symptoms in the elderly: a comparison between patients with heart failure and age-and gender-matched community controls. J Card Fail. 2009;15:17–23. doi:10.1016/j.cardfail.2008.09.006
   PubMed Web of Science ®Google Scholar
• Broström A, Strömberg A, Dahlström U, Fridlund B. Sleep difficulties, daytime sleepiness, and health-related quality of life in patients with chronic heart failure. J Cardiovasc Nurs. 2004;19:234–242. doi:10.1097/00005082-200407000-00003
   PubMedGoogle Scholar
• Cowie MR, Anker SD, Cleland JG, et al. Improving care for patients with acute heart failure: before, during and after hospitalization. ESC Heart Fail. 2014;1:110–145.
   PubMedGoogle Scholar
• Calvert MJ, Freemantle N, Cleland JG. The impact of chronic heart failure on health‐related quality of life data acquired in the baseline phase of the CARE‐HF study. Eur J Heart Fail. 2005;7:243–251. doi:10.1016/j.ejheart.2005.01.012
   PubMed Web of Science ®Google Scholar
• Faxén UL, Hage C, Donal E, Daubert JC, Linde C, Lund LH. Patient reported outcome in HFpEF: sex-specific differences in quality of life and association with outcome. Int J Cardiol. 2018;267:128–132. doi:10.1016/j.ijcard.2018.04.102
   Web of Science ®Google Scholar
• Friedman MM. Gender differences in the health related quality of life of older adults with heart failure. Heart Lung. 2003;32:320–327. doi:10.1016/S0147-9563(03)00098-0
   PubMed Web of Science ®Google Scholar
• Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet (London, England). 2003;362(9386):777–781. doi:10.1016/S0140-6736(03)14285-7
   PubMed Web of Science ®Google Scholar
• Solomon SD, McMurray JJV, Anand IS, et al. Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. NEJM. 2019;381:1609–1620. doi:10.1056/NEJMoa1908655
   PubMed Web of Science ®Google Scholar
• Lam CSP, Voors AA, Piotr P, McMurray JJV, Solomon SD. Time to rename the middle child of heart failure: heart failure with mildly reduced ejection fraction. Eur Heart J. 2020;41:2353–2355. doi:10.1093/eurheartj/ehaa158
   Web of Science ®Google Scholar
• Triposkiadis F, Butler J, Abboud FM, et al. The continuous heart failure spectrum: moving beyond an ejection fraction classification. Eur Heart J. 2019;40:2155–2163. doi:10.1093/eurheartj/ehz158
   PubMed Web of Science ®Google Scholar
• Novartis Entresto granted expanded indication in chronic heart failure by FDA; February 16, 2021. Available from: https://www.novartis.com/news/media-releases/novartis-entresto-granted-expanded-indication-chronic-heart-failure-fda. Accessed June 21, 2021.
   Google Scholar
• McMurray JJ, Packer M, Desai AS, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. NEJM. 2014;371:993–1004. doi:10.1056/NEJMoa1409077
   PubMed Web of Science ®Google Scholar
• Babineaux SM, Curtis B, Holbrook T, Milligan G, Piercy J. Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the Disease Specific Programme. BMJ Open. 2016;6:e010352. doi:10.1136/bmjopen-2015-010352
   PubMed Web of Science ®Google Scholar
• Higgins V, Piercy J, Roughley A, et al. Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015. Diabetes Metab Syndr Obes Targets Ther. 2016;9:371–380. doi:10.2147/DMSO.S120101
   PubMed Web of Science ®Google Scholar
• Anderson P, Benford M, Harris N, Karavali M, Piercy J. Real-world physician and patient behaviour across countries: disease-Specific Programmes - a means to understand. Curr Med Res Opin. 2008;24:3063–3072. doi:10.1185/03007990802457040
   PubMed Web of Science ®Google Scholar
• Rector TS, Kubo SH, Cohn JN. Patients’ self-assessment of their congestive heart failure. Part 2: content, reliability and validity of a new measure, The Minnesota Living with Heart Failure Questionnaire. Heart Fail. 1987;3:198–209.
   Google Scholar
• EuroQol--a new facility for the measurement of health-related quality of life. Health policy (Amsterdam, Netherlands). 16:199–208; 1990.
   Google Scholar
• Brooks R. EuroQol: the current state of play. Health Policy (Amsterdam, Netherlands). 1996;37:53–72. doi:10.1016/0168-8510(96)00822-6
   PubMed Web of Science ®Google Scholar
• Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727–1736. doi:10.1007/s11136-011-9903-x
   PubMed Web of Science ®Google Scholar
• Dyer MT, Goldsmith KA, Sharples LS, Buxton MJ. A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual Life Outcomes. 2010;8:13. doi:10.1186/1477-7525-8-13
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence (NICE). Position statement on use of the EQ-5D-5L valuation set for England; Updated October 2019. Available from: https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/technology-appraisal-guidance/eq-5d-5l. Accessed September 15, 2020.
   Google Scholar
• Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEconomics. 1993;4:353–365. doi:10.2165/00019053-199304050-00006
   PubMed Web of Science ®Google Scholar
• Brugts JJ, Linssen GCM, Hoes AW, Brunner-la Rocca HP. Real-world heart failure management in 10,910 patients with chronic heart failure in the Netherlands: design and rationale of the Chronic Heart failure ESC guideline-based Cardiology practice Quality project (CHECK-HF) registry. Neth Heart J. 2018;26:272–279. doi:10.1007/s12471-018-1103-7
   PubMed Web of Science ®Google Scholar
• van Deursen VM, Urso R, Laroche C, et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey. Eur J Heart Fail. 2014;16:103–111. doi:10.1002/ejhf.30
   PubMed Web of Science ®Google Scholar
• Jackson JD, Cotton SE, Bruce Wirta S, et al. Burden of heart failure on patients from China: results from a cross-sectional survey. Drug Des Devel Ther. 2018;12:1659–1668. doi:10.2147/DDDT.S148949
   PubMed Web of Science ®Google Scholar
• Wirta SB, Balas B, Proenca CC. et al. Perceptions of heart failure symptoms, disease severity, treatment decision-making, and side effects by patients and cardiologists: a multinational survey in a cardiology setting. Ther Clin Risk Manag;2018. 2265–2272. doi: 10.2147/TCRM.S183200
   Web of Science ®Google Scholar
• Jackson JD, Cotton SE, Bruce Wirta S, et al. Care pathways and treatment patterns for patients with heart failure in China: results from a cross-sectional survey. Drug Des Devel Ther. 2018;12:2311–2321. doi:10.2147/DDDT.S166277
   Web of Science ®Google Scholar
• Wilson J, McMillan S. Symptoms Experienced by Heart Failure Patients in Hospice Care. J Hosp Palliat Nurs. 2013;15:13–21. doi:10.1097/NJH.0b013e31827ba343
   Google Scholar
• Celano CM, Villegas AC, Albanese AM, Gaggin HK, Huffman JC. Depression and Anxiety in Heart Failure: a Review. Harv Rev Psychiatry. 2018;26:175–184. doi:10.1097/HRP.0000000000000162
   PubMed Web of Science ®Google Scholar
• Liguori I, Russo G, Curcio F, et al. Depression and chronic heart failure in the elderly: an intriguing relationship. J Geriatr Cardiol. 2018;15:451–459.
   Google Scholar
• Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol. 2006;48:1527–1537. doi:10.1016/j.jacc.2006.06.055
   PubMed Web of Science ®Google Scholar
• Polikandrioti M, Panoutsopoulos G, Tsami A, et al. Assessment of quality of life and anxiety in heart failure outpatients. Arch Med Sci Atheroscler Dis. 2019;4:e38–e46. doi:10.5114/amsad.2019.84444
   Google Scholar
• Lesman-Leegte I, Jaarsma T, Sanderman R, Linssen G, van Veldhuisen DJ. Depressive symptoms are prominent among elderly hospitalised heart failure patients. Eur J Heart Fail. 2006;8:634–640. doi:10.1016/j.ejheart.2005.11.010
   PubMed Web of Science ®Google Scholar
• Rumsfeld JS, Havranek E, Masoudi FA, et al. Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure. J Am Coll Cardiol. 2003;42:1811–1817. doi:10.1016/j.jacc.2003.07.013
   PubMed Web of Science ®Google Scholar
• Bilbao A, Escobar A, García-Perez L, Navarro G, Quirós R. The Minnesota living with heart failure questionnaire: comparison of different factor structures. Health Qual Life Outcomes. 2016;14:23. doi:10.1186/s12955-016-0425-7
   Web of Science ®Google Scholar
• Årestedt K, Saveman BI, Johansson P, Blomqvist K. Social support and its association with health-related quality of life among older patients with chronic heart failure. Eur J Cardiovasc Nurs. 2013;12:69–77. doi:10.1177/1474515111432997
   PubMed Web of Science ®Google Scholar
• de Rivas B, Permanyer-Miralda G, Brotons C, Aznar J, Sobreviela E. Health-related quality of life in unselected outpatients with heart failure across Spain in two different health care levels. Magnitude and determinants of impairment: the INCA study. Qual Life Res. 2008;17:1229–1238. doi:10.1007/s11136-008-9397-3
   Web of Science ®Google Scholar
• Gallagher AM, Lucas R, Cowie MR. Assessing health-related quality of life in heart failure patients attending an outpatient clinic: a pragmatic approach. ESC Heart Fail. 2019;6:3–9. doi:10.1002/ehf2.12363
   PubMed Web of Science ®Google Scholar
• Lupón J, Gastelurrutia P, de Antonio M, et al. Quality of life monitoring in ambulatory heart failure patients: temporal changes and prognostic value. Eur J Heart Fail. 2013;15:103–109. doi:10.1093/eurjhf/hfs133
   Web of Science ®Google Scholar
• Moradi M, Daneshi F, Behzadmehr R, Rafiemanesh H, Bouya S, Raeisi M. Quality of life of chronic heart failure patients: a systematic review and meta-analysis. Heart Fail Rev. 2019.
   Google Scholar
• Chandra A, Vaduganathan M, Lewis EF, et al. Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction: the PARAGON-HF Trial. JACC Heart Fail. 2019;7:862–874. doi:10.1016/j.jchf.2019.05.015
   PubMed Web of Science ®Google Scholar
• Comín-Colet J, Anguita M, Formiga F, et al. Health-related Quality of Life of Patients With Chronic Systolic Heart Failure in Spain: results of the VIDA-IC Study. Rev Esp Cardiol (Engl Ed). 2016;69:256–271. doi:10.1016/j.recesp.2015.07.034
   PubMed Web of Science ®Google Scholar
• Proudfoot C, Fonseca AF, Lahoz R, et al. Patients with heart failure and a LVEF less than 40% present an overall lower health related quality of life than those with LVEF between 40% and 60%: a multinational real-world survey in EU. Eur Heart J. 2020;41(Supplement_2). doi:10.1093/ehjci/ehaa946.0974
   Google Scholar
• Chen X, Xin Y, Hu W, et al. Quality of life and outcomes in heart failure patients with ejection fraction in different ranges. PLoS One. 2019;14(6). doi:10.1371/journal.pone.0218983
   Web of Science ®Google Scholar
• Karpf E, Jackson J, Cotton S, et al. Assessing the Burden of Chronic Heart Failure on Patients in Colombia. Value Health. 2017;20:A623. doi:10.1016/j.jval.2017.08.1362
   Web of Science ®Google Scholar
• Lawson CA, Zaccardi F, Squire I, et al. 20-year trends in cause-specific heart failure outcomes by sex, socioeconomic status, and place of diagnosis: a population-based study. Lancet Public Health. 2019;4:e406–e20. doi:10.1016/S2468-2667(19)30108-2
   Web of Science ®Google Scholar
• Guha K, McDonagh T. Heart failure epidemiology: european perspective. Curr Cardiol Rev. 2013;9:123–127. doi:10.2174/1573403X11309020005
   PubMedGoogle Scholar
• Hood SR, Giazzon AJ, Seamon G, et al. Association between medication adherence and the outcomes of heart failure. Pharmacotherapy. 2018;38:539–545. doi:10.1002/phar.2107
   Web of Science ®Google Scholar